Can anyone believe that we're down on the day we learn the PDUFA date for our drug. Some were trying to create doubt that the FDA would accept the BLA, that doubt is eliminated and while approval is never certain, the FDA is already quite familiar with the drug and I believe Soraya met the criteria the FDA required. I like the chances and believe that if it's to be approved they may do so well prior to the 28 November date.
I don't know what will be presented at ASCO, but if it doesn't spur the share price I would hope that the company holds a Science Day, it's something they've done in the past and I really think they need to get their message out on all that's happening here. This is not a one trick pony.
Gary
News 
Market Data 
Discover 
